{"id":"NCT03524339","sponsor":"University Hospitals Cleveland Medical Center","briefTitle":"Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery","officialTitle":"Perioperative Administration of Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2018-08-01","primaryCompletion":"2020-06-09","completion":"2020-06-09","firstPosted":"2018-05-14","resultsPosted":"2021-11-08","lastUpdate":"2021-11-08"},"enrollment":132,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Urinary Retention","Lower Urinary Tract Symptoms","Stress Urinary Incontinence","Pelvic Organ Prolapse"],"interventions":[{"type":"DRUG","name":"Placebo oral capsule","otherNames":[]},{"type":"DRUG","name":"Tamsulosin","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Tamsulosin","type":"EXPERIMENTAL"}],"summary":"This is a placebo controlled randomized controlled trial of perioperative use of tamsulosin to prevent postoperative urinary retention in female pelvic reconstructive surgery.","primaryOutcome":{"measure":"Postoperative Urinary Retention","timeFrame":"Within 72 hours of surgery","effectByArm":[{"arm":"Placebo","deltaMin":16,"sd":null},{"arm":"Tamsulosin","deltaMin":5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":["19130599","27004205","27824741","11135378","15245819","17475584","28424499","24642148","27286124","26099320","33894146"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":62},"commonTop":["Dizziness/lightheadedness"]}}